SCHEMBL24802456

SCHEMBL24802456

Cc1ccc(O)c(CC(=O)N(C)C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 1/20 0.49
HTT P42858 1/20 0.44
PCNA P12004 1/20 0.43
CSNK2A1 P68400 1/20 0.43
TRPA1 O75762 1/20 0.42
TP53 P04637 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
ANO1 Q5XXA6 1/20 0.40
ALOX15 P16050 4/20 0.38
HSD17B10 Q99714 3/20 0.38
ALDH1A1 P00352 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
LMNA P02545 3/20 0.37
HPGD P15428 3/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
ALOX12 P18054 1/20 0.37
KMT2A Q03164 1/20 0.37
ICMT O60725 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6583906 0.86 SRC (0.44) AMY1APCNACSNK2A1TRPA1ALOX15
SCHEMBL3133362 0.84 EGFR (0.47) PCNATP53TDP1ALOX15HSD17B10
SCHEMBL27500492 0.84 TAAR1 (0.44) HTTHSD17B10NPSR1LMNAHPGD
SCHEMBL24804887 0.81 PCNA (0.46) PCNATDP1ALDH1A1MEN1GAA
SCHEMBL30772157 0.81 POLB (0.46) HTTPCNAANO1ALOX15ALDH1A1
SCHEMBL3880143 0.81 HIF1A (0.53) HTTANO1ALOX15HSD17B10LMNA
SCHEMBL3823395 0.81 PCNA (0.43) HTTPCNAALOX15HSD17B10ALDH1A1
SCHEMBL27745589 0.79 SRC (0.56) AMY1AHTTCSNK2A1TRPA1TP53
SCHEMBL10421373 0.78 ALDH1A1 (0.47) PCNATDP1ALDH1A1HPGDKDM4E
SCHEMBL30148651 0.78 EGFR (0.43) PCNATDP1ANO1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022268209-A1 DERIVATIVE HAVING PYRIMIDINE-FUSED CYCLIC STRUCTURE, AND USE THEREOF 四川汇宇制药股份有限公司 2022-12-29 WO disclosed